Last week marked a significant reaffirmation for international drug control policy as 1,200 delegates, representing 120 countries and over 50 civil society organizations, convened in Vienna, Austria, for the 55th session of the Commission on Narcotic Drugs (CND). I had the honor to serve as part of the U.S. delegation led by Gil Kerlikowske, Director of the White House Office of National Drug Control Policy, and Brian Nichols, Principal Deputy Assistant Secretary of State for International Narcotics and Law Enforcement Affairs.
Over the course of the week, the U.S. delegation played a leading role in the unanimous adoption of 12 resolutions on issues ranging from preventing overdose deaths to addressing specific regional challenges to facilitating alternatives to imprisonment. We held more than 20 bilateral and multilateral meetings with other countries, led a panel discussion on drugged driving, and joined a panel on meeting the specific needs of drug-addicted women. The latter panel allowed us to highlight the first-ever U.S. National Action Plan on Women, Peace, and Security, as well as our ongoing support for domestic and international programs addressing women's needs and promoting gender equality.
Established in 1946 as a functional commission of the United Nations Economic and Social Council (ECOSOC), the CND reviews and analyzes the global drug control situation, considering the interrelated issues of drug abuse prevention, the rehabilitation of drug users, and preventing the supply and trafficking of illicit drugs. The CND is also responsible for supervising the application of international drug control treaties and advising ECOSOC on matters pertaining to the control of narcotic drugs, psychotropic substances, and their precursors. Resolutions negotiated at the annual sessions of the CND shape global drug control policy and direct the work of the UN Office of Drugs and Crime (UNODC) on these matters and related initiatives.
The 1912 Opium Convention was one of the first international treaties specifically aimed against a global threat. To recognize that historic event, and all the subsequent global cooperation strengthening international drug controls, the United States sponsored a resolution commemorating the 100th anniversary of the Convention. This resolution gained a record number of co-sponsors from around the globe, from Russia and China to European and Latin American countries, and recommitted all of us to continue fighting against illicit opiates; reducing drug production, trafficking, and use; and ensuring the availability of controlled drugs for medical and scientific purposes.
Additional CND resolutions further reinforced and expanded existing drug controls. For example, the CND adopted a novel resolution on gender-specific treatment and rehabilitation needs. Other resolutions included an electronic import/export authorization system to facilitate legal trade of controlled substances; reintegrating persons released from prison after they've renounced drug abuse; and international cooperation in responding to new psychoactive substances. The United States also co-sponsored a resolution put forth by Russia and France to address opiate trafficking in Afghanistan and its surrounding region.
We're already beginning to see operational results from the CND. One country noted that, in response to a resolution, it plans to look into using a life-saving drug that can help prevent deaths from overdose. For its part, the United States looks forward to working with other states, as well as UNODC, in various joint projects and regional counter-narcotics initiatives addressed in the resolutions.